Affimed N.V.盘中异动大幅上涨5.53%_老虎社区_美港股上老虎

Affimed N.V.盘中异动大幅上涨5.53%

市场透视2025-05-01

北京时间2025年05月01日22时10分，Affimed N.V.（AFMD.us）股票出现异动，股价快速拉升5.53%。截至发稿，该股报1.050美元/股，成交量2.8426万股，换手率0.17%，振幅4.02%。最近的财报数据显示，该股实现营业收入170274.48美元，净利润-16.63百万美元，每股收益-1.03美元，毛利--，市盈率-0.20倍。机构评级方面，在所有1家参与评级的机构中...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2532009392?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-01 22:10","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2532009392","market":"us","top_or_hot":-1,"title":"Affimed N.V.盘中异动 大幅上涨5.53%","media":"市场透视","content":"<div>\n<p>北京时间2025年05月01日22时10分，Affimed N.V.（AFMD.us）股票出现异动，股价快速拉升5.53%。截至发稿，该股报1.050美元/股，成交量2.8426万股，换手率0.17%，振幅4.02%。最近的财报数据显示，该股实现营业收入170274.48美元，净利润-16.63百万美元，每股收益-1.03美元，毛利--，市盈率-0.20倍。机构评级方面，在所有1家参与评级的机构中...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501221003a6d018cc&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Affimed N.V.盘中异动 大幅上涨5.53%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAffimed N.V.盘中异动 大幅上涨5.53%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-01 22:10 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501221003a6d018cc&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月01日22时10分，Affimed N.V.（AFMD.us）股票出现异动，股价快速拉升5.53%。截至发稿，该股报1.050美元/股，成交量2.8426万股，换手率0.17%，振幅4.02%。最近的财报数据显示，该股实现营业收入170274.48美元，净利润-16.63百万美元，每股收益-1.03美元，毛利--，市盈率-0.20倍。机构评级方面，在所有1家参与评级的机构中...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501221003a6d018cc&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AFMD","symbol_name":"Affimed NV","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501221003a6d018cc&s=b","article_id":"2532009392","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501221003a6d018cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2532009392","pubTimestamp":1746108603,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月01日22时10分，Affimed N.V.股票出现异动，股价快速拉升5.53%。截至发稿，该股报1.050美元/股，成交量2.8426万股，换手率0.17%，振幅4.02%。Affimed N.V.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Transcode Therapeutics, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Transcode Therapeutics, Inc.、Processa Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为137.83%、40.72%、17.95%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cyclacel Pharmaceuticals, Inc.，振幅分别为36.89%、24.75%、20.14%。Affimed N.V.公司简介：Affimed NV是一家处于临床阶段的生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"AFMD":"Affimed NV","BK4139":"生物科技"},"translate_title":"Affimed N.V. jumps 5.53% in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AFMD":0.9},"content_text":"北京时间2025年05月01日22时10分，Affimed N.V.（AFMD.us）股票出现异动，股价快速拉升5.53%。截至发稿，该股报1.050美元/股，成交量2.8426万股，换手率0.17%，振幅4.02%。最近的财报数据显示，该股实现营业收入170274.48美元，净利润-16.63百万美元，每股收益-1.03美元，毛利--，市盈率-0.20倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Affimed N.V.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Transcode Therapeutics, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 (To Pur Com)、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)涨幅较大，Transcode Therapeutics, Inc.、Processa Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为137.83%、40.72%、17.95%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Cyclacel Pharmaceuticals, Inc.，振幅分别为36.89%、24.75%、20.14%。Affimed N.V.公司简介：Affimed NV是一家处于临床阶段的生物制药公司。该公司致力于发现和开发癌症靶向免疫疗法。其候选产品正在开发免疫肿瘤学领域，这是一种利用人体的免疫防御能力来对抗肿瘤细胞的癌症治疗方法。它以其核心技术积极致力于抗体的发现、临床前和临床开发。 该公司通过向第三方提供基于集团和第三方拥有的知识产权的研发服务来获得收入。 从地理位置来看，该公司的大部分收入来自美国，并且在德国和德国也有业务。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}